NCT02906839View on ClinicalTrials.gov

Sleep Apnea and Atrial Fibrillation Recurrence

NACompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

September 23, 2022

Study Completion Date

November 22, 2023

Conditions

Sleep Apnea SyndromeAtrial Fibrillation

Interventions

OTHER

Intervention group

Just after AF ablation, nocturnal polygraphy will be performed to diagnose SAS. If present and AHI \>15/h, the SAS will be treated, based on type and severity of SAS and on patient tolerance to treatment.

Trial Locations (1)

75018

Hôpital Bichat-Claude Bernard, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02906839 - Sleep Apnea and Atrial Fibrillation Recurrence | Biotech Hunter | Biotech Hunter